Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02873884
What this trial is testing

Impact of Case-management on Therapeutic Alliance With First Episode Psychosis Patients (CAMAT)

Who this might be right for
Psychotic Disorders
University Hospital, Caen 30
Large-scale testing (Phase 3)Study completedNCT01709084
What this trial is testing

A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment

Who this might be right for
Human Immunodeficiency Virus-type 1 Infection
Janssen-Cilag International NV 426
Not applicableStudy completedNCT01637233
What this trial is testing

MARCH Central Nervous System Substudy

Who this might be right for
HIV-1 Infection
Kirby Institute 28
Not applicableUnknownNCT05798871
What this trial is testing

Efficacy of Subgingival Erythritol Air Polishing in Treatment of Periodontal Pockets

Who this might be right for
Periodontal Diseases
University of Baghdad 25
Testing effectiveness (Phase 2)Study completedNCT03415802
What this trial is testing

Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Aiping Zhou 32
Testing effectiveness (Phase 2)Study completedNCT00783367
What this trial is testing

Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas

Who this might be right for
Follicular LymphomaMarginal Zone B-Cell LymphomaMALT Lymphoma+4 more
Abramson Cancer Center at Penn Medicine 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT06405100
What this trial is testing

Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD

Who this might be right for
Minimal Change Disease
Air Force Military Medical University, China 81
Testing effectiveness (Phase 2)UnknownNCT03986294
What this trial is testing

Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 122
Testing effectiveness (Phase 2)Study completedNCT00633594
What this trial is testing

Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
SCRI Development Innovations, LLC 39
Post-approval studies (Phase 4)Study completedNCT00389194
What this trial is testing

PREventing Progression of Adipose Tissue Redistribution

Who this might be right for
HIV Infections
International Antiviral Therapy Evaluation Center 120
Large-scale testing (Phase 3)Study completedNCT02668653
What this trial is testing

Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid LeukemiaLeukemia
Daiichi Sankyo 539
Not applicableStudy completedNCT01524445
What this trial is testing

Retrospective Survey of Re-treatment With Bortezomib

Who this might be right for
Hematological CancerMultiple Myeloma
Janssen Pharmaceutica N.V., Belgium 35
Not applicableStudy completedNCT04133012
What this trial is testing

Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 20
Large-scale testing (Phase 3)Ended earlyNCT03656536
What this trial is testing

Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma

Who this might be right for
Unresectable CholangiocarcinomaMetastatic Cholangiocarcinoma
Incyte Corporation 167
Testing effectiveness (Phase 2)UnknownNCT00961077
What this trial is testing

Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer

Who this might be right for
ElderlyS-1Oxaliplatin+2 more
Soonchunhyang University Hospital 36
Testing effectiveness (Phase 2)Ended earlyNCT05448677
What this trial is testing

Ezurpimtrostat Autophagy Inhibitor in Association With Atezolizumab-Bevacizumab in First Line Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Grenoble 3
Early research (Phase 1)Study completedNCT01507077
What this trial is testing

ZGN-440 (Beloranib for Subcutaneous Injection) for Treatment of Obesity

Who this might be right for
Obesity
Zafgen, Inc. 25
Not applicableStudy completedNCT04226469
What this trial is testing

Gingival Crevicular Fluid Characterization During Orthodontic Treatment

Who this might be right for
HealthyMaxillary First Premolar Tooth ExtractionCanine Retraction
University of Illinois at Chicago 15
Large-scale testing (Phase 3)Looking for participantsNCT06809322
What this trial is testing

Vorasidenib Maintenance for IDH Mutant Astrocytoma

Who this might be right for
IDH-mutant Grade 2 or 3 Astrocytoma
European Organisation for Research and Treatment of Cancer - EORTC 468
Not applicableLooking for participantsNCT06994377
What this trial is testing

Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy

Who this might be right for
Metastatic Breast Cancer
European Institute of Oncology 1,000
Next Page